← Back to headlines
Scribe Secures $129M in Gene Editing IPO
Scribe successfully secured $129 million in a rare gene editing IPO, marking a significant event in the biotechnology sector.
23 Jul, 21:18 — 23 Jul, 21:18
Sources
Showing 1 of 1 sources
Scribe successfully secured $129 million in a rare gene editing IPO, marking a significant event in the biotechnology sector.
